What is the ticker symbol for Midatech Pharma?

Midatech Pharma trades under the ticker MTP on NASDAQ.

What sector does Midatech Pharma operate in?

Midatech Pharma is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze MTP in a portfolio?

PortView shows MTP's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Midatech Pharma (MTP) Stock Analysis

NASDAQHealthcareBiotechnology

$0.29-18.50%

1-year price historyRange $0.13 – $3.24

52-week range$0.29

$0.19$20.80

What Midatech Pharma does

Midatech Pharma plc is a pharmaceutical company focused on the research and development of drug delivery technologies and therapeutic solutions across the United Kingdom, Europe, and international markets. Its active pipeline includes MTX110, an investigational direct-delivery treatment for aggressive brain tumors such as diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme. Also in development are MTX114, a topical immunosuppressant for managing psoriasis; MTD211, an extended-release formulation of brexpiprazole for schizophrenia and as an adjunct for major depressive disorder; and MTD219, a long-acting version of tacrolimus designed to mitigate the risk of organ transplant rejection. The company also leverages proprietary drug delivery platforms: Q-Sphera, a polymer microsphere microtechnology for sustained drug release; MidaSolve, an oligosaccharide nanotechnology enabling the solubilization and direct, localized liquid administration of drugs into tumors; and MidaCore, a gold nanoparticle system engineered for targeted delivery of chemotherapeutic or immunotherapeutic agents to disease sites. Founded in 2000, Midatech Pharma plc is headquartered in Cardiff, United Kingdom.

Key metrics

Market cap

$1.98M

P/E (TTM)

-0.14

EPS (TTM)

$-2.06

Beta

1.22

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$1.50

200-day avg

$6.83

52-week high

$20.80

52-week low

$0.19

CEO

Stephen A. Stamp

ETFs linked to MTP

Broad-market and Healthcare sector ETFs an investor holding Midatech Pharma is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how MTP fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze MTP in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Midatech Pharma?: Midatech Pharma trades under the ticker MTP on NASDAQ.
Which exchange is MTP listed on?: MTP is listed on NASDAQ.
What sector does Midatech Pharma operate in?: Midatech Pharma is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze MTP in a portfolio?: PortView shows MTP's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.